Empowering Parkinson’s patients to declare pain: A multicenter report of the use of the first Parkinson’s pain questionaire (King’s PD pain quest)
Objective: To report the use of the first and easy to use self-completed Parkinson's specific pain questionnaire (King's PD Pain Quest (KPPQ), which is complementary…The high prevalence of pain among patients with X linked dystonia parkinsonism
Objective: To evaluate the frequency of pain and its severity among XDP (X linked dystonia parkinsonism) patients. Background: Sex-linked dystonia parkinsonism (XDP, DYT3, "Lubag") is…Does GPi-DBS help non motor symptoms in cervical dystonia patients? A retrospective study of 17 patients
Objective: To study the efficacy of GPi DBS surgery in improving dystonia related severity, disability and pain as well as quality of life in medically…Painful legs and moving toes (PLMT) treatment with topic capsaicin: A case report
Objective: To describe a case of painful legs and movement toes successfully treated with topical capsaicin. Background: A 77yo man with depression and dyslipidaemia complained…Inhibition of nociceptive responses by modulating serotonergic signals at the rostral ventromedial medulla in 6-OHDA-induced Parkinson’s disease rat model
Objective: We aimed to determine whether the descending 5-HT facilitatory pathway from rostral ventromedial medulla (RVM) and the extracellular 5-HT in RVM are involved in…Exploring hospitalizations and visits to the emergency room of patients with Parkinson’s disease: A ten years’ follow-up
Objective: To describe the number and reasons of the visits to the emergency room (ER) and the hospitalizations of Parkinson's disease (PD) patients for a…Exercise induced analgesia is present in people with Parkinson’s disease
Objective: To investigate if exercise-induced analgesia (EIA) is present in people with Parkinson's disease (PD) compared to an age-matched control group. Background: Pain is a…Preclinical evaluation of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias: Is it a ‘chemical’ DBS?
Objective: To evaluate mechanism of long-term activity of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias (LID). Background: Ketamine is an anesthetic that, when administered as…Neuropsychiatric disturbances in Parkinson’s disease patients’ with chronic pain
Objective: The study objective was to assess the neuropsychiatric profile in Moldavian Parkinson's disease patients with chronic pain. Background: Psychological factors can influence both the…Patient case reports supporting a long-term effect of sub-anesthetic ketamine infusion in reducing L-DOPA-induced dyskinesias
Objective: To evaluate possible long-term anti-dyskinetic activity of low-dose sub-anesthetic ketamine infusion from a retrospective chart review. Background: Repurposing drugs that have already been proven…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.